Regulus Therapeutics Inc.
| Use attributes for filter ! | |
| Stock price | RGLS |
|---|---|
| Disclaimer | |
| Headquarters | Carlsbad |
| California | |
| United States | |
| Number of employees | 65 |
| Founded | September 2007 |
| Parent organizations | Alnylam Pharmaceuticals |
| Ionis Pharmaceuticals | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 1165249 |
About Regulus Therapeutics Inc.
Regulus Therapeutics Inc. or Regulus is a clinical stage biopharmaceutical company focused on the development of first-in-class drugs that target microRNAs to treat a broad range of diseases. Regulus was established in September 2007 by Alnylam Pharmaceuticals and Isis Pharmaceuticals.
